PRDM13 Activators
The activators for PR Domain Containing 13 (PRDM13) target a range of cellular processes and signaling pathways, thereby influencing PRDM13 activity. These compounds mainly act on epigenetic regulation and developmental signaling pathways. DNA methyltransferase inhibitors like 5-Azacytidine and HDAC inhibitors such as Trichostatin A can modulate chromatin structure and gene expression, impacting PRDM13's transcriptional regulatory function. EZH2 inhibitors and BET bromodomain inhibitors affect chromatin modifications and transcriptional regulation, which could influence PRDM13.
LSD1 inhibitors impact histone methylation, a key epigenetic mark, possibly affecting PRDM13's role in gene regulation. Modulators of developmental pathways like Wnt, Hedgehog, NOTCH, and TGF-beta could also impact PRDM13's function in these processes. Inhibitors of signaling pathways such as JAK/STAT, mTOR, and PI3K/Akt, known for their roles in cell growth, differentiation, and survival, might also have effects on PRDM13. These compounds do not specifically target PRDM13 but influence cellular processes and pathways that could modulate PRDM13's activity or expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
These inhibitors can alter DNA methylation patterns, potentially impacting PRDM13's role in transcriptional regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitors affect chromatin structure and gene expression, potentially influencing PRDM13. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Inhibiting Hedgehog signaling may impact developmental processes involving PRDM13. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
By inhibiting JAK/STAT signaling, these compounds might influence processes involving PRDM13. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
Modulating TGF-beta signaling could impact cellular processes relevant to PRDM13. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibiting the PI3K/Akt pathway could indirectly affect PRDM13 through various signaling pathways. | ||||||